HROWL -
Harrow, Inc. 8.625% Senior Notes due 2026
| Day |
1m |
10m |
60m |
PreMarket |
Market |
AfterHours |
Gap |
| --- |
--- |
--- |
--- |
--- |
--- |
--- |
--- |
Earnings & Ratios
- Basic EPS:
- 0.14
- Diluted EPS:
- 0.13
- Basic P/E:
- Diluted P/E:
- RSI(14) 1m:
- 0.0
- VWAP:
- 25.28
- RVol:
Events
| Period |
Kind |
Movement |
Occurred At |
Related News
Could Harrow's New Sedation Pill Change Millions Of Medical Procedures Forever?
Sep 26, 2025 12:57
Harrow to Acquire Melt Pharmaceuticals
Sep 26, 2025 11:00
Harrow Announces Pricing of $250.0 Million Offering of Senior Unsecured Notes Due 2030
Sep 08, 2025 21:57
Harrow Announces Offering of $250.0 Million Senior Unsecured Notes Due 2030
Sep 08, 2025 12:00
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
Aug 01, 2025 14:00
Nicox Announces Last Patient Completes Final Visit in NCX 470 Phase 3b Whistler Glaucoma Trial
Mar 19, 2025 06:30
US Futures Show Caution Among Investors Ahead Of FOMC Meeting: Analysts Say Only Certainty Is That 'Things Will Remain Uncertain For The Time Being'
Mar 18, 2025 10:16
Nicox Presents New Analysis from the NCX 470 Mont Blanc Trial and Provides Development Update
Mar 03, 2025 06:30
Nicox : Présentation Scientifique et Participation aux Congrès du premier semestre 2025
Jan 28, 2025 06:30
Nicox Announces Scientific Presentation and Conference Attendance in H1 2025
Jan 28, 2025 06:30